Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/VREO stock hub

CSE/VREO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/VREOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

766.8M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/VREO

In the news

Latest news · CSE/VREO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.1

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-37.5

P25 -121.5P50 -40.9P75 0.5

ROIC2.4

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/VREO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	612
Employees Change	92%
Employees Change Percent	17.69
Enterprise value	CAD 1B
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	CAD 766.8M
Price	CAD 0.52
Price currency	CAD
Rev Per Employee	651,086.43x
Sector	Healthcare
Sic	2834
Symbol	cse/VREO
Website	https://www.vireogrowth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.18%
EV Earnings	-11.15x
EV/EBIT	74.77x
EV/EBITDA	22.51x
EV/FCF	-30.87x
EV/Sales	2.83x
FCF yield	-4.4%
Forward P/E	11.06x
P/B ratio	1.82x
P/S ratio	2.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.78%
EBITDA Margin	10.14%
Gross margin	47.29%
Gross Profit	CAD 174.3M
Gross Profit Growth	150.33%
Gross Profit Growth Q	349.59%
Gross Profit Growth3 Y	60.21%
Gross Profit Growth5 Y	49.31%
Net Income	CAD -93.4M
Pretax Margin	-14.85%
Profit Margin	-25.34%
Profit Per Employee	CAD -165,004
ROA	1.16
Roa5y	-0.45
ROCE	1.62
ROE	-37.53
ROIC	2.36
Roic5y	4.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.89%
Cagr3y	25.19%
Cagr5y	-28.49%
Revenue Growth	170.44x
Revenue Growth Q	317.65x
Revenue Growth3 Y	53.28x
Revenue Growth5 Y	40.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.49
Assets	CAD 1.1B
Cash	CAD 141.6M
Current Assets	CAD 417.1M
Current Liabilities	CAD 261.8M
Debt	CAD 416.4M
Debt EBITDA	CAD 9
Debt Equity	CAD 0.99
Debt FCF	CAD -12.34
Equity	CAD 421.5M
Interest Coverage	0.34
Liabilities	CAD 698.9M
Long Term Assets	CAD 703.3M
Long Term Liabilities	CAD 437.1M
Net Cash	CAD -274.8M
Net Cash By Market Cap	CAD -35.84
Net Debt EBITDA	CAD 7.36
Net Debt Equity	CAD 0.65
Tangible Book Value	CAD 140.4M
Tangible Book Value Per Share	CAD 0.13
WACC	5.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.59
Inventory Turnover	3.47
Net Working Capital	CAD 43.2M
Quick ratio	0.73
Working Capital	CAD 155.7M
Working Capital Turnover	CAD 3.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-307.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.89%
200-day SMA	0.73
3Y total return	96.23%
50-day SMA	0.57
50-day SMA vs 200-day SMA	50under200
5Y total return	-81.29%
All Time High	6.87
All Time High Change	-92.43%
All Time High Date	2019-04-08
All Time Low	0.13
All Time Low Change	300%
All Time Low Date	2023-03-30
ATR	0.05
Beta	0.04
Beta1y	0.08
Beta2y	-0.01
Ch YTD	-37.35
High	0.54
High52	1.08
High52 Date	2025-08-12
High52ch	-51.85%
Low	0.51
Low52	0.46
Low52 Date	2025-09-03
Low52ch	14.29%
Ma50ch	-8.77%
Price vs 200-day SMA	-28.56%
RSI	40.89
RSI Monthly	43.89
RSI Weekly	39.62
Sharpe ratio	0.49x
Sortino ratio	0.8
Total Return	-307.3%
Tr YTD	-37.35
Tr1m	-5.45%
Tr1w	-11.86%
Tr3m	-27.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 13.9M
Operating Income Growth	-43.77
Operating Income Growth Q	-28.57
Operating margin	3.78

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	936,225,966%
Net Borrowing	24,960,722.6
Shares Insiders	11.65%
Shares Institutions	14.92%
Shares Out	1,474,571,103
Shares Qo Q	10.81%
Shares Yo Y	307.3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -51.5M
Average Volume	102,542.55x
Bv Per Share	0.39
CAPEX	CAD -38.8M
Ch1m	-5.45
Ch1w	-11.86
Ch1y	-1.89
Ch3m	-27.78
Ch3y	96.23
Ch5y	-81.29
Ch6m	-35
Change	1.96%
Change From Open	0
Close	0.51
Days Gap	1.96
Depreciation Amortization	23,356,388.3
Dollar Volume	5,439.2
Earnings Date	2026-05-12
EBIT	CAD 13.9M
EBITDA	CAD 37.4M
EPS	CAD -0.13
F Score	4
FCF	CAD -33.7M
FCF EV Yield	-3.24x
FCF Per Share	CAD -0.02
Financing CF	25,254,740
Fiscal Year End	December
Founded	2,004
Goodwill	119,664,121.6
Income Tax	CAD 38.7M
Investing CF	12,010,258
Is Primary Listing	1
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Ma150	0.71
Ma150ch	-26.62%
Ma20	0.59
Ma20ch	-11.64%
Net CF	42,353,898
Next Earnings Date	2026-05-12
Open	0.52
P OCF Ratio	150.7
Position In Range	33.33
Ppne	370,297,949
Price Date	2026-05-08
Price EBITDA	CAD 20.53
Ptbv Ratio	5.46
Relative Volume	0.1x
Revenue	368,514,919x
SBC By Revenue	4.82x
Share Based Comp	17,751,489
Tax By Revenue	10.49x
Tr6m	-35%
Volume	10,460
Z Score	0.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/VREO pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/VREO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/VREO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.9%

Share of float held by funds and institutions

Insider ownership

+11.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+307.3%

Negative means the company is buying back shares.

Technical

CSE/VREO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.9

Neutral momentum band

Price vs 200-day MA

-28.6%

50/200-day relationship not available

Beta (5Y)

0.04

Less volatile than the market

Sharpe ratio

0.49

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/VREO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/VREO stock rating?

cse/VREO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/VREO analysis?

The full report lives at /stocks/cse/VREO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/VREO?

The latest report frames cse/VREO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/VREO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.